当前位置: X-MOL 学术Gen. Thorac. Cardiovasc. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A case of thymoma showing significant tumor reduction after anti-thymocyte globulin
General Thoracic and Cardiovascular Surgery ( IF 1.2 ) Pub Date : 2021-10-28 , DOI: 10.1007/s11748-021-01721-2
Hiroki Hayashida 1 , Akira Honda 1 , Toshiya Hino 1 , Hideaki Mizuno 1 , Kazuhiro Toyama 1 , Mineo Kurokawa 1, 2
Affiliation  

A 71-year-old female with type B3 thymoma developed severe aplastic anemia. Anti-thymocyte globulin was administered with glucocorticoids and cyclosporin A as the treatment for aplastic anemia. Computed tomography scan revealed that thymoma apparently shrank and remained without regrowth for at least 7 months. As previously reported, glucocorticoid has therapeutic effects on thymoma especially with abundant lymphocytes. Anti-thymocyte globulin also depletes peripheral lymphocytes, but its efficacy in the treatment of thymoma is unknown. Anti-thymocyte globulin and glucocorticoids may have cooperated with each other in reducing thymoma in our case. More cases should be accumulated to elucidate the effects of anti-thymocyte globulin on thymoma.



中文翻译:

胸腺瘤一例抗胸腺细胞球蛋白后肿瘤明显缩小

一名患有 B3 型胸腺瘤的 71 岁女性出现严重的再生障碍性贫血。抗胸腺细胞球蛋白与糖皮质激素和环孢菌素 A 一起用于治疗再生障碍性贫血。计算机断层扫描显示胸腺瘤明显缩小,至少 7 个月没有再生。如前所述,糖皮质激素对胸腺瘤有治疗作用,尤其是对淋巴细胞丰富的胸腺瘤。抗胸腺细胞球蛋白也会消耗外周淋巴细胞,但其治疗胸腺瘤的功效尚不清楚。在我们的病例中,抗胸腺细胞球蛋白和糖皮质激素可能在减少胸腺瘤方面相互合作。应积累更多病例,阐明抗胸腺细胞球蛋白对胸腺瘤的作用。

更新日期:2022-01-06
down
wechat
bug